Orthotopic liver transplantation in an adult with cholesterol ester storage disease

JIMD Reports

Volumn 8, Issue , 2013, Pages 41-46

  Ambler, Graeme K ^a   Hoare, Matthew ^a   Brais, Rebecca ^a   Shaw, Ashley ^a   Butler, Andrew ^a   Flynn, Paul ^a   Deegan, Patrick ^a   Griffiths, William J H ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Enzyme replacement therapy; Hepatic artery thrombosis; Lysosomal acid lipase deficiency; Orthotopic liver transplantation; Transjugular intrahepatic portosystemic shunt

Indexed keywords

EID: 84901820071     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2012_155     Document Type: Chapter

References (22)

1. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation 120:1640–1645
2. Anderson RA, Byrum RS, Coates PM et al (1994) Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci USA 91:2718–2722
3. Anderson RA, Rao N, Byrum RS et al (1993) In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3. Genomics 15:245–247
4. Anderson RA, Sando GN (1991) Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J Biol Chem 266:22479–22484
5. Arterburn JN, Lee WM, Wood RP et al (1991) Orthotopic liver transplantation for cholesteryl ester storage disease. J Clin Gastroenterol 13:482–485
6. Barber KM, Pioli SE, Blackwell JE et al (2007) Development of a UK score for patients with end-stage liver disease. Hepatology 46:510A
7. Chatrath H, Keilin S, Attar BM (2009) Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult. Dig Dis Sci 54:168–173
8. Du H, Cameron TL, Garger SJ et al (2008) Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J Lipid Res 49:1646–1657
9. Elleder M, Chlumska A, Hyanek J et al (2000a) Subclinical course of cholesteryl ester storage disease in an adult with hypercholester-olemia, accelerated atherosclerosis, and liver cancer. J Hepatol 32:528–534
10. Elleder M, Chlumska A, Ledvinova J et al (2000b) Testis-a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma. Virchows Arch 436:82–87
11. Elleder M, Ledvinova J, Cieslar P et al (1990) Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process. Virchows Arch A 416:357–365
12. Enns G (2012) Initial human experience with sbc-102, a recombinant enzyme replacement therapy in adults with lysosomal acid lipase deficiency. Presented at the 8th Annual Lysosomal Disease Network (LDN) World Symposium
13. Ferry GD, Whisennand HH, Finegold MJ et al (1991) Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr 12:376–378
14. Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470
15. Leone L, Ippoliti PF, Antonicelli R (1991) Use of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiency. J Pediatr 119:1008–1009
16. Leone L, Ippoliti PF, Antonicelli R et al (1995) Treatment and liver transplantation for cholesterol ester storage disease. J Pediatr 127:509–510
17. Lewsey JD, Dawwas M, Copley LP et al (2006) Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors. Transplantation 82:898–907
18. Maslen CL, Babcock D, Illingworth DR (1995) Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease. J Inherit Metab Dis 18:620–623
19. McCoy E, Yokoyama S (1991) Treatment of cholesteryl ester storage disease with combined cholestyramine and lovastatin. Ann NY Acad Sci 623:453–454
20. Muntoni S, Wiebusch H, Jansen-Rust M et al (2007) Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol 27:1866–1868
21. Natarajan P, Ray KK, Cannon CP (2010) High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol 55:1283–1299
22. Pisciotta L, Fresa R, Bellocchio A et al (2009) Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. Mol Genet Metab 97:143–148